NCT06785441
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Efficacy Testing
Recruiting · Not specified · M.D. Anderson Cancer Center · registry updated 2025-02-04
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
This protocol describes pilot testing of an educational shared decision-making intervention to help men with localized prostate cancer make decisions with their health care providers about if and when to de-escalate surveillance testing. The project is important because for many patients their cancer does not progress to the point of needed curative treatment or their health status changes such that they are no longer good candidates for treatment. For these men, de-escalating ongoing surveillance (e.g., fewer biopsies or imaging studies) is a reasonable option.
Inclusion
- Males aged 65 or older
- Diagnosis of localized prostate cancer
- Have not received curative intent treatment for their prostate cancer
- Fluent in English
- Care partners/caregivers:
- Aged 18 or older
Exclusion
- \. Currently receiving treatment for another cancer (primary or recurrence)
- Care partners/caregivers